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Targeted single molecule sequencing
methodology for ovarian hyperstimulation
syndrome
Funda Orkunoglu-Suer1*, Arthur F Harralson2, David Frankfurter3, Paul Gindoff3 and Travis J O’Brien4

Abstract
Background: One of the most significant issues surrounding next generation sequencing is the cost and the
difficulty assembling short read lengths. Targeted capture enrichment of longer fragments using single molecule
sequencing (SMS) is expected to improve both sequence assembly and base-call accuracy but, at present, there are
very few examples of successful application of these technologic advances in translational research and clinical testing.
We developed a targeted single molecule sequencing (T-SMS) panel for genes implicated in ovarian response to
controlled ovarian hyperstimulation (COH) for infertility.
Results: Target enrichment was carried out using droplet-base multiplex polymerase chain reaction (PCR) technology
(RainDance®) designed to yield amplicons averaging 1 kb fragment size from candidate 44 loci (99.8% unique base-pair
coverage). The total targeted sequence was 3.18 Mb per sample. SMS was carried out using single molecule, real-time
DNA sequencing (SMRT® Pacific Biosciences®), average raw read length = 1178 nucleotides, 5% of the amplicons >6000
nucleotides). After filtering with circular consensus (CCS) reads, the mean read length was 3200 nucleotides (97% CCS
accuracy). Primary data analyses, alignment and filtering utilized the Pacific Biosciences® SMRT portal. Secondary analysis
was conducted using the Genome Analysis Toolkit for SNP discovery l and wANNOVAR for functional analysis of variants.
Filtered functional variants 18 of 19 (94.7%) were further confirmed using conventional Sanger sequencing. CCS reads were
able to accurately detect zygosity. Coverage within GC rich regions (i.e.VEGFR; 72% GC rich) was achieved by capturing
long genomic DNA (gDNA) fragments and reading into regions that flank the capture regions. As proof of concept,
a non-synonymous LHCGR variant captured in two severe OHSS cases, and verified by conventional sequencing.
Conclusions: Combining emulsion PCR-generated 1 kb amplicons and SMRT DNA sequencing permitted greater
depth of coverage for T-SMS and facilitated easier sequence assembly. To the best of our knowledge, this is the
first report combining emulsion PCR and T-SMS for long reads using human DNA samples, and NGS panel designed
for biomarker discovery in OHSS.
Keywords: Single-molecule sequencing, Droplet-based PCR, Emulsion PCR, Next generation DNA sequencing, Ovarian
hyperstimulation syndrome, OHSS

Background
Sequence capture enrichment strategies and single molecule sequencing (SMS) are expected to increase the rate
of gene discovery for genetically heterogeneous diseases.
There have been several recent reports on the successful
application of SMS to interrogate both viral [1-4] and
bacterial [3,5-10] genomes. At present, there are very
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few examples of successful application of these technologic advances in translational research and clinical testing in humans. Recently, the targeted exon sequencing
of 238 cancer gene mutations from tumor/blood samples
using the PacBio RS platform was reported indicating
that achieving longer reads with SMS was feasible in human samples [11]. In that study, target enrichment was
achieved through the generation of amplicons averaging
340 bp in length.
More than one million couples worldwide seek reproductive assistance each year because of infertility [12].
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Unfortunately, infertility therapy involving controlled
ovarian stimulation (COH) may result in potentially
fatal iatrogenic ovarian hyperstimulation syndrome (OHSS).
OHSS reported as leading cause of maternal mortality in
UK [13]. The overarching objective of this study was to
identify predictive genetic biomarkers for outcome to controlled ovarian hyperstimulation (COH). Patient response to
COH is variable and likely influenced by a diverse array of
genetic (and epigenetic) factors requiring sophisticated nextgeneration sequencing (NGS) techniques for elucidation. To
date, there have been no tools developed to query all regions
(including intronic and 5′ and 3′UTR flanking sequences)
of candidate genes for COH and its major iatrogenic complication, ovarian hyperstimulation syndrome (OHSS). We
have developed a targeted SMS (T-SMS) panel containing
44 loci that have been implicated in either response to COH
or OHSS. Our approach utilized droplet-based emulsion
PCR for the generation of 1913 amplicons averaging 1 kb in
length for T-SMS. We report the successful development
and implementation of this novel technique and an offer
proof of concept of its utility.

Methods
Sample collection and processing

This study was approved by George Washington University
Institutional Review Board. It was open to all adult
(>18 years of age) female patients recruited previously
treated or currently seeking OHSS treatment at the
GW Fertility and IVF Center. Written informed consent for participation was obtained from the participants prior to sample collection. Wet lab and dry lab
work carried out within Genetics in Medicine Research
Institute of Children’s National Medical Center. Ovarian hyperstimulation syndrome, non-responders and
hyper-responders to ovarian simulation were defined
clinically based on the criteria established by Navot
[14,15]. Approximately 5 mL of blood was collected
for genetic analysis.
Total genomic DNA was extracted from 200 uL
EDTA anti-coagulated venous blood using magnetic
beads (Maxwell® 16 DNA Kit DNA Purification Kit
(Promega, US) on a fully automated system. DNA (1 uL)
quality and quantity was measured (260/280 and 260/230
ratio) using a Qubit dsDNA HS assay kit and system
(Invitrogen, US). Samples showing RNA contamination
(260/280 ratio >2) were discarded and samples with a
260/230 ratio less than one were excluded from further
processing. DNA was quantified in duplicate for each
sample and the mean value was used for further calculations. DNA integrity (1 uL) was analyzed using an E-Gel®
Agarose Gel Electrophoresis System on a 0.8% agarose gel.
Samples showing fragmentation were discarded and reisolated from fresh patient samples. DNA (3 mg) was sonicated using a Covaris S220 system (Covaris, US) for 180 s
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to ~5 kb fragment size (20% duty cycle, 5 intensity,
200 cycles per burst).
Target gene list and primer design

The target gene list was developed from an extensive literature search. It included genes that were a) implicated
in COH response, b) associated with OHSS or c) regulated gonadotropin action and/or ovarian angiogenesis.
Genes included in the target list either a) harbored variants associated with COH outcome, b) displayed differential expression (mRNA, protein) in OHSS and/or 3)
played a significant role in gonadotropin signaling or in
regulating vascular permeability in the ovary. The Genomic targets were comprehensive and included intronic,
exonic, 5′ and 3′ untranslated regions (UTRs) of the target
genes. The total targeted sequence consisted of 3.18 Mb
covering 44 loci with 1X tiling (see Additional file 1). The
primer library was designed using the manufacturer’s parameters (Rain Dance Technologies, US) and all primers
were first tested with Primer3 (http://frodo.wi.mit.edu/
primer3/). The primer design pipeline performed an
exhaustive primer selection across all of the regions
submitted and generated 1951 unique amplicons (average
amplicon length ~1 kb) using 3756 primers (Tm = 55-65°C,
99.8% success rate). Repeat masking was not performed on
the input regions to the primer design pipeline. Primers
were designed to provide ~100 bp overlap between adjacent amplicons and avoided primer binding to SNPs and
repeat regions. There was no allele dropouts discovered in
the final design.
Droplet-Based multiplex amplification

Amplification was carried out similar to previously described methods [16] and according to the manufacturer’s
protocol. Following amplification each PCR emulsion was
broken to release individual amplicons from the PCR
droplets and samples were purified using a MinElute column (Qiagen, US) following the manufacturer’s recommended protocol. Purified amplicons were then tested on
an Agilent Bioanalyzer (Agilent, US) and Qubit (Qiagen,
US) to assure quality and quantity and confirm that the
amplicon profile matches the expected histogram profile.
Library construction and single molecule, Real-Time
sequencing (SMRT)

Amplicons (1 μg) were converted to SMRTbell™ templates using the PacBio® RS DNA Template Preparation
Kit (catalog #001-322-716), incubated for 15 min at 25°C
and further purified with a 0.6X AMPure XP clean-up
kit and eluted in 30 μl buffer. Blunt adapters were ligated to each amplicon to facilitate circle replication
[SMRTbell™ template sequencing] and to permit error
control by calculating the consensus (‘circular consensus
sequence’ or CCS). Exonuclease incubation was carried
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Table 1 Data pipeline
Primary Analyses

Q metrics

SMRT standard pipeline

Secondary Analyses

BLASR de novo CCS aligner
algorithm filter v1 (hg19)

BLASR de novo CCS aligner algorithm was used for SNP calling using
CCS reads. Reads were filtered by length/quality and mapped to
reference sequence (UCSC, hg19). Base quality scores were recalibrated,
and consensus Filter v1: Min Read Length bp: 50, Minimum Sub Read
Length 50

GATK

Overview

Variants identified using the GATK Unified Genotyper for Bayesian diploid
and haploid SNP calling using base quality score recalibration and default
settings. Indel calling was not included in SMRT pipeline

Overview

SMART view, UCSC Genome browser, R circos plot, Partek

ANNOVAR
Data visualization

Functional annotation of variants

out in order to remove all unligated adapters. Samples
were extracted twice (0.6X AMPure beads) and the final
“SMRT bells” were eluted in 10 μl EB. Final quantification was carried out on an Agilent 2100 Bioanalyzer with
1 μl of library. The amount of primer and polymerase
required for the binding reaction was determined using
the SMRT bell concentration (ng/μl) and insert size previously determined using the manufacturer-provided calculator. Primers were annealed and polymerase was
bound using the DNA/Polymerase Binding Kit 1.0 (PacBio
catalog #001-359-802). The complexes were stored at
−20°C or diluted for immediate sequencing.
Sequencing mixes were diluted to the required concentration with the manufacturer provided dilution buffer prior to loading onto 96-well plates. Sample plates
were loaded onto the instrument along with the DNA
Sequencing Kit 1.0 (catalog #001-379-044). Sequencing
was performed using PacBio SMRT sequencing technology as previously described (4) using a SMRT Cell
8Pac. In all sequencing runs, 2 x 45 min movies were
captured for each SMRT Cell loaded with a single binding
complex.
Data analyses

The data analyses pipeline is provided in Table 1. Primary filtering analysis was first performed using the PacBio RS server prior to data being transferred to the
SMRT Portal using the SMRT analysis pipeline version
1.3.3 (http://www.smrtcommunity.com/SMRT-Analysis/
Software/SMRT-Pipe); http://www.pacificbiosciences.com/
products/pacificbio-rs-workflow-main/). Secondary analysis was conducted using the Genome Analysis Toolkit
(GATK) (http://www.broadinstitute.org/gatk/) embedded
in the SMRT Portal. Output files (VCF and BAM files) were
transferred to wANNOVAR (http://wannovar.usc.edu/) for
variant (SNP) calling (relative to reference sequence
assembly; hg19). The project was registered with the
NIH bioproject database (http://www.ncbi.nlm.nih.gov/
bioproject/193545). All sequence data was made accessible from the NIH next generation sequence read archive
(SRA) data base (http://www.ncbi.nlm.nih.gov/Traces/sra).

Sanger validation of variants

Validation of SMS variants was conducted by Sanger DNA
sequencing as previously described [17]. Primers were designed using the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov) and University of
Santa Cruz Genome Browser (https://genome.ucsc.edu).
Multiple sequence alignments were carried out using
ChromasPro software (Technelysium Pty Ltd). All variants were reported according to standard nomenclature.
(http://www.hgvs.org/mutnomen/)

Results and discussion
Single molecule sequencing of DNA libraries

We targeted the entire coding region (exons/introns)
and the 3′ and 5′ UTR non-coding sequences of 44 candidate loci covering ~3.18 Mb per sample. Our primer
design yielded 3756 primer pairs that generated 1951
amplicons that were confirmed to be 1 kb in length (not
shown). Amplicons were tiled to have an average overlap
of 100 base pairs (bp) to facilitate coverage and assembly.
For the SMS-generated raw reads the average read length
was 1178 nucleotides (nt) and ~5% were >6000 nt.
SMS (2 chips per sample) was successful in capturing
100% sequence information from 1816 out of the 1951
amplicons targeted (93.1%). After filtering for circular
consensus (CCS) reads, the mean read length was
3200 nt which was likely due to the use of a longer
Table 2 Characteristics of captured sequence
Characteristic

Result

Sequence yield per run (pre filter base)

800 Mb

Sequence run per sample

2 chips

Run time

2 movies, 45 min each

Mean Accuracy

10X CCS, 97.3%

Targeted Accuracy

10 X CCS, 100%

Mean Read length

3200 nt

Mean mapped read length

900 bp

Insert size

1 kb

DNA requirements

500 ng/uL
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sequencing protocol to accommodate the larger size
(1 kb) of the amplicons (Table 2). The mean mapped
CCS read accuracy was 97%. A small percentage (5%)
of consensus reads of were >6215 nt.
We generated average 900 bp mean mapped subreads
with a mean zero-mode waveguide (ZMW) occupancy
of 85%. In our primary design, we calculated target
coverage depth using the manufacturer’s formula (6).
Based on this, we used 2 chips per sample and SMS data
were collected in 2 x 45-min movies to attain 17X targeted CCS coverage depth. These results are in agreement with recent targeted sequencing studies shown to
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have higher coverage depth than exome and whole genome sequencing using different enrichment strategies
[18]. Previous work has suggested that 10X CCS coverage depth (or 50X single read coverage = QV50) can accurately (100%) distinguish between heterozygous and
homozygous SNPs [17]. Consequently, our filtering was
set to a minimum cut-off of 10 X CCS coverage depth.
Repetitive sequences

Guanine-cytosine (GC)-rich regions of the genome pose
significant challenges for high-throughput DNA sequencing. We were able to sequence 1 kb amplicons generated

Figure 1 Read length vs. GC coverage. This is a representative example of typical read length and coverage (A) of GC rich regions (VEGFA
gene) and sequence results imported as custom track in UCSC Genome Browser. Fragments (1 kb) were tiled to cover the entire genomic region
of the VEGFA gene (grey bars above sequence). There were a total of 42 amplicons (intragenic sequences totaled 34,268 bp) with 50–150 bp
overlap. B. Screen capture showing the high GC content (72%) of the VEGFA gene which was successfully 005B1:1] sequenced.
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from GC-rich regions in our targeted sequences. Moreover, we were able to align these GC-rich sequences with
similar success as non-GC-rich regions which is consistent with other reports [6]. As proof of concept, Figure 1
shows tiled coverage of the VEGFA gene using total 42
amplicons (Figure 1A). VEGFA has ~72% GC content
(Figure 1B). The uniform coverage for three representative
samples aligned against the hg19 reference sequence is
provided in the circos plot in Figure 2.
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Confirmation of T-SMS base calls

Base-call accuracy is of great concern with next generation sequencing technologies. We have validated 19
SNPs identified by T-SMS with Sanger DNA sequencing.
For those exonic variants identified by T-SMS, 18 of 19
(94.7%) of the SNPs were verified by Sanger DNA sequencing. As an example, Figure 3 shows the validation
of rs12470652 in the luteinizing hormone choriogonadotropin receptor (LHCGR) gene. This missense variant

Figure 2 Uniform Coverage between amplicons using Droplet PCR with SMS technology. Circos plot illustrating the relative coverage of
target sequences in 3 samples. Outermost blue displays target genomic sequence with respect to chromosomal location. For each target
sequence, the percentage GC content is provided in purple (scale 0–100). The bases covered for bait regions are shown in green (scale 1–1000).
The coverage of SMS for 3 representative samples is provided in red.
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Figure 3 Validation of rs12470652 identified by T-SMS. SMRT® View screenshot of secondary data analysis from SMRT® Portal (A and B).
Validation of the LHCGR rs12470652 heterozygous variant discovered using T-SMS by Sanger DNA sequencing. The figure depicts the process of
biomarker identification by SMS (A and B) and validation by conventional Sanger sequencing (C).

(NP_000224.2:p. Asn291Ser; T > C) passed all the filters
and variant annotation analyses steps (Figure 3A) and
was further validated using conventional Sanger sequencing (Figure 3B) and here we report it in two severe
OHSS patients.

Conclusions
Targeted sequencing approaches are advantageous for
enriching variant identification, simplifying data analysis
and avoiding ethical issues surrounding incidental findings. We have developed a custom protocol and data
processing pipeline for generating 1 kb amplicons by
emulsion PCR for T-SMS. Our preliminary analysis has
initially focused on coding region variants in each of our
44 candidate loci for OHSS. Although smaller amplicons
may theoretically yield more readings than larger fragments, we have found that fixed/same size and longer
amplicons work effectively with droplet PCR enrichment
combined with SMS. Employing T-SMS technology has

provided improved resolution by yielding longer reads
and sequencing many target genes in a relatively short
period of time (45 min). Moreover, T-SMS of large
amplicons had low composition bias and an error profile that is orthogonal to other next generation sequencing platforms that have promise for clinical diagnosis.
To the best of our knowledge, this is the first study
reporting the successful sequencing of 1 kb amplicons
utilizing droplet PCR combined with SMS technology
from human samples. These data show excellent promise
for follow-up studies with a larger number of OHSS
cases.
Availability of supporting data

Supporting data is included as additional files. Project
details and Sequence Data registered and can be found
in the publicly available databases: http://www.ncbi.nlm.
nih.gov/bioproject/193545 http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2808927/.

Orkunoglu-Suer et al. BMC Genomics (2015) 16:264

Additional file
Additional file 1: Targeted gene list.
Abbreviations
SMS: Single molecule sequencing; COH: Controlled ovarian hyperstimulation;
OHSS: Ovarian hyperstimulation syndrome; NGS: Next generation DNA
sequencing; PCR: Polymerase chain reaction; GDNA: Genomic DNA;
CCS: Circular Consensus Sequencing; SMRT®: Single molecule, real-time;
T-SMS: Targeted SMS; ZMW: Zero-mode waveguide; SNP: Single
nucleotide polymorphism.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
FS, designed the study and conducted the experiments, data analyses, and
drafted the paper. PG and DF identified patients and collected biomaterial.
TJO participated in study design, conducted experiments and analysis and
drafted the paper. AH participated in study design and analysis and drafted
the paper. All authors participated in drafting the paper. All authors read and
approved the final manuscript.
Acknowledgements
This study was funded by award Number UL1RR031988 from the National
Center for Research Resources (T.J.O). The content is solely the responsibility
of the authors and does not necessarily represent the official views of the
National Center for Research Resources or the National Institutes of Health.
Author details
1
Department of Integrated System Biology, The George Washington
University Medical Center, Washington, DC 20037, USA. 2Department of
Pharmacogenomics, Bernard J. Dunn School of Pharmacy, Shenandoah
University, Ashburn, VA, USA. 3Department of Obstetrics and Gynecology,
The George Washington University Medical Center, Washington, DC 20037,
USA. 4Department of Pharmacology and Physiology, The George Washington
University Medical Center, Washington, DC, 20037.

Page 7 of 7

10. Hoefler BC, Konganti K, Straight PD. De Novo Assembly of the Streptomyces
sp. Strain Mg1 Genome Using PacBio Single-Molecule Sequencing. Genome
announcements. 2013;1(4).
11. Tran B, Brown AM, Bedard PL, Winquist E, Goss GD, Hotte SJ, et al. Feasibility of
real time next generation sequencing of cancer genes linked to drug
response: results from a clinical trial. Int J Cancer. 2013;132(7):1547–55.
12. Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS,
de Mouzon J, et al. European Ivf-monitoring Consortium ftESoHR, Embryology:
Assisted reproductive technology and intrauterine inseminations in Europe,
2005: results generated from European registers by ESHRE: ESHRE. The
European IVF Monitoring Programme (EIM), for the European Society of
Human Reproduction and Embryology (ESHRE). Human reproduction.
2009;24(6):1267–87.
13. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al.
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood
safer: 2006–2008. The Eighth Report of the Confidential Enquiries into
Maternal Deaths in the United Kingdom. BJOG. 2011;118(1):1–203.
14. Bergh PA, Navot D. Ovarian hyperstimulation syndrome: a review of
pathophysiology. J Assist Reprod Genet. 1992;9(5):429–38.
15. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in
novel reproductive technologies: prevention and treatment. Fertil Steril.
1992;58(2):249–61.
16. Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH, et al.
Microdroplet-based PCR enrichment for large-scale targeted sequencing.
Nat Biotech. 2009;27(11):1025–31.
17. O’Brien TJ, Kalmin MM, Harralson AF, Clark AM, Gindoff I, Simmens SJ, et al.
Association between the luteinizing hormone/chorionic gonadotropin
receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation
syndrome during controlled ovarian hyperstimulation. Reprod Biol
Endocrinol. 2013;11(1):71.
18. Clark MJ, Chen R, Lam HY, Karczewski KJ, Chen R, Euskirchen G, et al.
Performance comparison of exome DNA sequencing technologies. Nat
Biotechnol. 2011;29(10):908–14.

Received: 14 May 2014 Accepted: 9 March 2015

References
1. Schmuki MM, Erne D, Loessner MJ, Klumpp J. Bacteriophage P70: unique
morphology and unrelatedness to other Listeria bacteriophages. J Virol.
2012;86(23):13099–102.
2. Archer J, Weber J, Henry K, Winner D, Gibson R, Lee L, et al. Use of four
next-generation sequencing platforms to determine HIV-1 coreceptor
tropism. PLoS One. 2012;7(11):e49602.
3. Coupland P, Chandra T, Quail M, Reik W, Swerdlow H. Direct sequencing of
small genomes on the Pacific Biosciences RS without library preparation.
BioTechniques. 2012;53(6):365–72.
4. Schleiss MR, McAllister S, Armien AG, Hernandez-Alvarado N, Fernandez-Alarcon C,
Zabeli JC, et al. Molecular and biological characterization of a new isolate of guinea
pig cytomegalovirus. Viruses. 2014;6(2):448–75.
5. Powers JG, Weigman VJ, Shu J, Pufky JM, Cox D, Hurban P. Efficient and
accurate whole genome assembly and methylome profiling of E. coli. BMC
genomics. 2013;14:675.
6. Ferrarini M, Moretto M, Ward JA, Surbanovski N, Stevanovic V, Giongo L, et al.
An evaluation of the PacBio RS platform for sequencing and de novo
assembly of a chloroplast genome. BMC Genomics. 2013;14:670.
7. Rehvathy V, Tan MH, Gunaletchumy SP, Teh X, Wang S, Baybayan P, et al..
Multiple Genome Sequences of Helicobacter pylori Strains of Diverse
Disease and Antibiotic Resistance Backgrounds from Malaysia. Genome
announcements. 2013;1(5).
8. Koren S, Harhay GP, Smith TP, Bono JL, Harhay DM, McVey SD, et al.
Reducing assembly complexity of microbial genomes with single-molecule
sequencing. Genome Biol. 2013;14(9):R101.
9. Khosravi Y, Rehvathy V, Wee WY, Wang S, Baybayan P, Singh S, et al.
Comparing the genomes of Helicobacter pylori clinical strain UM032 and
Mice-adapted derivatives. Gut pathogens. 2013;5(1):25.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

